Reappearance of beta-adrenergic receptors after isoproterenol treatment in intact C6-cells by unknown
Reappearance of/3-Adrenergic 
Treatment in Intact C6-Cells 
Receptors after Isoproterenol 
CORNELIA  HERTEL and  MATTHYS  STAEHELIN 
Friedrich Miescher-lnstitut,  CH-4002 Basel, Switzerland 
ABSTRACT  The reappearance of/3-adrenergic receptors in C6-glioma cells after desensitization 
with  isoproterenol was studied using the antagonist [3H]CGP-12177. Reappearance  had the 
following properties: (a) it occurred in intact cells only, (b) it was temperature dependent, (c) 
it required an Na+/H + gradient, low intracellular Ca  2÷ activity, and (d) it required ATP, and (e) 
intact lysosomes.  The results suggest endocytosis and recycling of the ~-adrenergic receptor 
after agonist treatment. 
Cells  that possess  ~-adrenergic receptors become refractory 
when  they  are  continuously exposed  to  ~-adrenergic hor- 
mones. Two different mechanisms have been proposed to be 
involved in this process:  firstly,  a fast,  reversible "desensiti- 
zation" of the agonist-induced adenylate cyclase activity and, 
secondly, a  slow decrease in the total number of receptors, 
i.e., "down regulation" of the receptors (l, 2). The desensiti- 
zation of adenylate cyclase is suggested to be due to a change 
in  the  conformation of the  receptor enzyme complex (1). 
Prolonged treatment of cells with an agonist has been dem- 
onstrated to lead to internalization of  the receptor (3) followed 
by cycling through lysosomes (4).  These authors suggested 
that down regulation is mediated by receptor endocytosis. It 
is still unclear whether these two processes, i.e., desensitization 
of the adenylate cyclase and down regulation of the receptors, 
are linked and in what way this coupling occurs. 
Harden et al.  (5) have demonstrated that parallel to the 
densensitization  of the  adenylate  cyclase,  in  addition  to 
plasma membrane receptors, a  second, physically separable 
receptor population appeared. This second receptor popula- 
tion  occurred in  a  vesicular receptor fraction while at the 
same  time the  number of receptors bound  to  the  plasma 
membrane fraction was reduced. They suggested  that endo- 
cytosis of ~-adrenergic receptors occurs already during desen- 
sitization and not only during down regulation. The change 
in the properties of the B-adrenergic  receptor during desensi- 
tization has been  further investigated, using a  new,  hydro- 
philic ~-adrenergic antagonist  [3H]CGP-12177  that became 
recently available (6,  7).  The main  advantage of this  new 
ligand compared with the established ~-adrenergic antagonists 
is that it cannot pass membranes and thus is not accumulated 
inside cells (8). Thus, using [3H]CGP-12177, the number of 
~-adrenergic receptors on the cell surface could be determined 
in intact cells. In intact cells, agonist treatment did induce a 
loss  of agonist-stimulated adenylate cyclase (1),  which also 
causes a decrease in the number of those ¢/-adrenergic recep- 
tors being available for [3H]CGP-12177 (8, 9). At the same 
time the  total  number of/3-adrenergic receptors, as deter- 
mined with a lipophilic ligand,  was still constant. 
Therefore, [3H]CGP-12177  is a tool to measure in intact 
cells  (8)  the  agonist-induced disappearance  of cell  surface 
receptors, which has been demonstrated before by Harden et 
al.  (5)  after lysing  the  cells.  Using  this ligand,  it has been 
demonstrated recently that the disappearance of B-adrenergic 
receptors is transient and is followed by a fast reappearance 
of receptors after removal of the agonist (8). 
In the present paper we demonstrate further characteristics 
of  this reappearance of  C/-adrenergic receptors in C6 rat glioma 
cells  following desensitization.  The results suggest  that the 
agonist-induced transient decrease in the number of ¢~-adre- 
nergic  receptors is  due  to  an  intracellular  recycling of 8- 
adrenergic receptors. 
MATERIALS  AND  METHODS 
Cell culture media were obtained from Gibco Laboratories (Grand Island, NY). 
[aH]CGP-12177 (1.48 x  1012 Bq/mmol) was prepared as described previously 
(7). [~4C]Leucine (1.2 x  10 '° Bq/mmol) was obtained  from NEN (Dreieich, 
FRG).  Chloroquine,  cycloheximide,  FCCP  (carbonyl-cyanide-p-trifluoro- 
methoxyl-phenylhydrazone),  antimycin  A, 2-deoxyglueose, l-isoproterenol bi- 
tartrate were obtained from Sigma Chemical Co. (St. Louis, Me), and valino- 
mycin, monensin, and A 23187 from Calbiochem (Luzern, Switzerland). 
Cells:  C6-glioma cells (10) were grown for 4 d in  10 ml of Dulbecco's 
modified Eagle's medium (DME) ~  containing  10% fetal calf serum in 100-mm 
~) Falcon tissue culture dishes (Falcon Labware, Oxnard, CA) to a density of 2 
x  107 cells. The cells were then detached by treatment  with 5 ml of ice-cold 
0.02% buffered EDTA solution per dish (11) and suspended in ice-cold DME- 
J  Abbreviations  used in this paper:  DME,  Dulbecco's modified Ea- 
gle's medium. 
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with sodium hydroxide to pH 7.3) at a density of ~3 x  106 cells/ml. 
Desensitization of ~-Adrenergic Receptors:  l-lsoproterenol(1 
#M final concentration)  was added to the growth medium of confluent  cells. 
The ceils were incubated for 15-20 rain at 37"C, rapidly chilled, washed twice 
with ice-cold DME-HEPES and detached by incubation  with ice-cold buffered 
0.02% EDTA solution for 4 rain. After aspiration of the EDTA solution, they 
were resuspended in DME-HEPES to a final density of ~3 x  l06 cells/ml. 
Ligand Binding:  To determine  nonspecific and total binding,  106 cells 
were incubated with varying amounts of [~H]CGP- 12177 with or without  l #M 
l-proprano[ol, respectively, in a total volume of  0.5 ml with shaking to prevent 
sedimentation  of the cells. The number of binding sites, B,,=, was determined 
by incubation  of the cells with 0.06-1  nM [3H]CGP-12177 for 90 min at 37"C 
or for 24 h at 4"C. 
For the  determination  of the  rate  of receptor  reappearance,  cells were 
incubated  with 3 nM [3H]CGP-12177 (7 x  KD) at the temperature  indicated 
for different times. They were immediately  chilled and then incubated  for an 
additional  24 h at 4"C to allow the binding to reach equilibrium. 
Before filtration,  the aliquots  were diluted  20-fold with  ice-cold 50  mM 
K~HPO4/KH2PO4 buffer containing  8 mM MgSO4, pH 7,5. They were then 
filtered through Whatman GF/C filters (Whatman Laboratory  Products  Inc., 
Wbatman Paper  Div, Clifton,  N  J) and washed twice with the above  buffer. 
The filters were taken  up in  10 ml of Aquasol-2 scintillation  fluid (NEN) for 
the determination  of radioactivity. 
Cells were lysed in 5 mM HEPES containing  1 mM MgSO4, pH 7.3. Aliquots 
of the lysates (0.45 ml) were incubated  with 50 ~1 of the radioligand with or 
without  1 uM  1-propranolol, at 37"C for the times indicated. 
A 23187, monensin, valinomycin,  FCCP, and antimycin  A were dissolved 
in absolute ethanol and diluted into the incubation  medium to a final concen- 
tration of 1% ethanol. The same amount of ethanol was added to the controls. 
A 0.5 M EDTA stock solution was first buffered with KOH to pH 8.9, so that 
the drop in pH expected to occur by the  1.36 mM Ca  2+ present in the medium 
was kept to a tolerable minimum. It was diluted  100-fold into the incubation 
assay. Chloroquine  and  2-deoxyglueose were dissolved  in  DME-HEPES  as 
stated. 
Protein Synthesis:  Detached cells 2 x  106 cells/ml were incubated at 
37"C in DME-HEPES containing  3.7 x  104 Bq of [~4C]leucine for 2 h with and 
without  10 zg cycloheximide/ml.  Incorporation  of [~4C]leucine into  protein 
was determined according to Paszkowski et al. (12). 
ATP and Protein Determination:  The intracellular  ATP was de- 
termined using ATP-bioluminescence (CLS) assay kit from Boehringer (Mann- 
helm, FRG) by the method described for intact cells in their product  manual. 
Protein was determined  with the dye-binding method of Spector (13). 
Calculations:  Scatchard analysis was used to determine  KD and B,,~ 
(14). B,,., was highly dependent  on the number of passages through which cells 
have grown. Therefore,  to compare independent  experiments,  the number of 
binding  sites was calculated  as a percentage of the control  value, which was 
determined for each experiment. Each experiment was carried out at least three 
times.  Results of single experiments  are shown except where otherwise indi- 
cated. 
RESULTS 
Binding of [3H]CGP- 12177: Disappearance of l~- 
Adrenergic Receptors after lsoproterenol 
Treatment 
For standard  experiments  a  concentration  range  of 0.06 
nM-I  nM  [3H]CGP-12177  was  used.  The  inset  in  Fig.  1 
shows that  the chosen  concentrations cover a  complete  S- 
shaped binding curve. At least two of the concentrations used 
were above the inflection point of the semi-logarithmic curve. 
According to Klotz (l 5), under these conditions it is legitimate 
to determine B,,ax as the intercept  in a Scatchard graph (14). 
Binding  of  [3H]CGP-12177  to  intact  C6-glioma  cells 
showed a KD of 0.36 _+ 0.02 nM (mean _+ SE; n =  10) at 37°C 
(Fig.  1). Additional incubation at 4"C resulted  in a decrease 
Of KD to 0.10 _+ 0.01  nM (n =  3), similar  to a KD of 0.12 ___ 
0.01  nM (n =  12) determined at 4"C without preincubation 
at 37"C (Fig.  1). The maximal number of binding sites (Bin,x) 
was not altered  by changing the incubation temperature.  In 
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FIGURE  1  Reversible decrease of binding sites after isoproterenol 
treatment. Isoproterenol-pretreated (open symbols) or control ceils 
(closed symbols) were incubated with [3H]CGP-12177 at either 4°C 
for 24  h  (circles) or  37°C  for 90  min  (squares). (inset) 5emiloga- 
rithmic graph of the data shown in Fig. 1. 
the experiment shown in Fig.  1, Bma~ was calculated  to be 14 
fmol/106 cells. When cells were pretreated at 37"C for 20 min 
with isoproterenol, the KD for  [3H]CGP- 12177 binding was 
0.35 _+ 0.04 nM (n =  9) at 37"C and 0.12 + 0.01 nM (n =  13) 
at 4"C. The value for/i'D was not significantly  different  from 
those obtained without isoproterenol pretreatment.  After de- 
sensitization Bm,x was determined as 14 fmol/106 cells at 37"C 
and as  10  fmol/106  cells at 4"C (Fig.  1).  Pretreatment  with 
isoproterenol thus  reduced the  number of binding sites  by 
30%.  This reduction could only be determined at 4"C, and 
not after incubation for 90 min at 37"C. 
Reappearance of ~-Adrenergic Receptors after 
Desensitization 
RATE OF APPEARANCE"  Desensitized cells were washed 
extensively to remove isoproterenol, then the time course of 
reappearance  of/~-adrenergic  receptors was measured at 37"C, 
as described  in Materials  and Methods. 
Fig. 2 shows that in intact cells within 3 min ~50%  of the 
desensitized receptors  had reappeared  (O) and after  60 min 
the number of binding sites had reached the value determined 
for control cells (@). 
Intactness  of the cells is required for the reappearance  of/~- 
adrenergic  receptors,  since a hypotonic shock prevented the 
reappearance  completely (Fig. 2, I). 
TEMPERATURE  DEPENDENCE"  The  kinetics  of reap- 
pearance was determined at three different temperatures (Fig. 
3). At 33"C (@) all binding sites had reappeared after 60 min; 
at 21"C (O) after about 6 h. At  13"C (E]), even after 6 h the 
number of/~-adrenergic  receptors  increased  only from 75% 
to 85%  of the total number of receptors.  The inset in Fig.  3 
shows the temperature dependence of receptor reappearance, 
which is nonlinear. 
ENERGY DEPENDENCE:  Confluent C6-cells were incu- 
bated with 20 mM 2-deoxyglucose or 10 #M antimycin A or 
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FIGURE  2  Kinetics  of  reappearance  of  [3H]CGP-12177  binding 
sites at 37°C.  Isoproterenol-treated cells  (O),  control cells  (O),  or 
cells that were lysed after isoproterenol treatment (1) were incu- 
bated with  3 nM  [3H]CGP-12177 at 370C for the times indicated, 
chilled, and incubated for a further 24 h at 4°C. For intact cells the 
amount of bound  ligand  is given as  femtomole per  106 cells;  for 
lysates it is given as fentomole per milligram protein. 
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FIGURE 3  Temperature dependence of the reappearance of [3H]- 
CGP-12177  binding sites. After isoproterenol pretreatment, cells 
were incubated at different temperatures. In each experiment the 
total number of binding sites was determined after 60 mid at 37"C. 
The data from the single experiments were normalized to that value 
(mean --- SE; n =  6). The data are shown for 330C  (O), 21 *C (O), 
and 13 °C (E3). (inset) Temperature dependence of reappearance of 
CGP-I 2177 binding sites after 15 miD. Percentage of reappearance 
of binding sites after 15 rain was calculated and plotted as a function 
of temperature.  The difference between  the  number of binding 
sites at O- and at 60-rain incubation at 37°C was set arbitrarily at 
100%.  The  temperature  dependence  of  the  kinetics  has  been 
determined as described above. 
2-deoxyglucose plus antimycin A for 20 min at 37"C. Table I 
shows  that  incubation  with  both  compounds  reduced  the 
intracellular ATP content by two orders of magnitude. Incu- 
bation with either one of them reduced the intracellular ATP 
content  by  50%.  As  we  have  shown  previously (16),  this 
reduction  of intracellular ATP-content  did  not  inhibit the 
desensitization of the  B-adrenergic receptors.  To  lower the 
ATP-concentration sufficiently during the  time of receptor 
reappearance, we incubated the cells with 2-deoxyglucose and 
antimycin A  for 20 min at 37"C together with isoproterenol. 
Afterwards, the cells were washed extensively and incubated 
for 90  min  at  37°C  with CGP-12177  (conditions where all 
receptors reappeared [see Fig.  1]) in the absence or presence 
of 20 mM 2-deoxyglucose and  10 ~zM antimycin A. Fig. 4A 
shows that/~-adrenergic receptors in desensitized cells reap- 
peared within  90  min  at  37"C,  giving the same  number  of 
receptors as determined in control cells (18  fmol/106 cells). 
In contrast, in Fig. 4 B the number of receptors in desensitized 
cells was  still reduced by  30%  (14  over 20  fmol/106  cells), 
when  2-deoxyglucose  and  antimycin  A  were  still  present 
during the incubation with CGP- 12177 at 37"C. This indicates 
that the reduction of the intracellular ATP concentration has 
prevented the reappearance of receptors. 
CATION  DEPENDENCE=  l0 •M  A  23187  (a Ca  2+ iono- 
phore) was added to the incubation medium in the presence 
of 1.36  mM CaCl2 to increase the intracellular Ca  2÷ activity. 
The  rate  of the  reappearance of the  /3-adrenergic receptors 
was  determined  at  32"C  as  described  under  experimental 
procedures (Fig. 5.4). The increased intracellular Ca  2÷ activity 
TABLE  I 
Intracellular A TP Content after Inhibition by GIycosis and 
Mitochondrial Electron Transport Chain 
Intracellular ATP 
Addition  concentration 
mM 
None  2.30 _+ 0.16 
2-Deoxyglucose (20 raM)  1.34 _+ 0.04 
Antimycin A* (10 ~M)  1.62 +  0.02 
Antimycin A  +  2-deoxyglucose  0.04 ±  0.01 
Cells were incubated for 20 rain with antimycin A and/or deoxyglucose. The 
ATP-content was determined after denaturation of the cells. To calculate the 
intracellular ATP concentration a volume of 1.8 ,~1/106  cells was used (mean 
_+ SEn = 6). 
*n=3. 
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FIGURE  4  Energy dependence of the reappearance of~-adrenergic 
receptors. All cells were treated with 20 mM 2-deoxyglucose and 
10/~M antimycin A  with  (O)  or without (O)  1 /~M  /-isoproterenol. 
After  extensive washing  the  cells  were  incubated  for  90  min  at 
37°C with CGP-12177 either in the absence (A) or in the presence 
(B) of 20 mM 2-deoxyglucose and  10/~M antimycin A. 
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FUGURE  5  Ion sensitivity of the reappearance of/~-adrenergic re- 
ceptors. Cells were pretreated with 1 ~M/-isoproterenol for 15 min 
at 37°C. After extensive washing, the rate of reappearance of/~- 
adrenergic receptors was determined at 33°C as binding of [~H]- 
CGP-12177.  The amount of [3H]CGP-12177  bound at 0 min was 
set arbitrarily to 0. (A) 10/~M A 23187 (O) or 10 #M A 23187 and 5 
mM  EGTA (O)  were  added  after  washing the  cells.  (B)  During 
incubation with I-isoproterenol, cells were treated with 5 ~M vali- 
nomycin, 5/~M FCCP, and 10 #M antimycin A (O), or with 50/~M 
monensin (O). The  same  concentrations of the  ionophore were 
added again after washing the cells. 
reappearance is not completely inhibited.  Addition  of vali- 
nomycin alone did not inhibit the reappearance of/3-adrener- 
gic receptors (data not shown). 
DEPENDENCE  ON  INTACT  LYSOSOMES:  To  increase 
the  intralysosomal  pH,  we  used  the  lysosomotropic agent 
chloroquine (17). Cells were preincubated with 0.1 mM chlor- 
oquine for 4 h at 37°C, a time period that has been described 
to  be sufficient to accumulate chloroquine  inside  the lyso- 
somes and increase their pH (18).  1 #M  1-isoproterenol was 
added for an additional  15 rain. After the cells were washed 
chloroquine was added again and the number of 13-adrenergic 
receptors was determined  either at  4°C  or at  37°C.  Fig.  6 
shows that in chloroquine-pretreated cells incubated with [3H]- 
CGP-12177  at 4°C  following desensitization the number of 
binding sites was reduced by 50% (15  fmol/106 cells [0] vs. 
30  fmol/106  cells  [O]).  Thus,  chloroquine  did  not  inhibit 
desensitization. When the cells were incubated at 37°C, how- 
ever, this 50% reduction is still  seen (123 vs. II) in contrast to 
the complete reappearance of receptors in cells not treated 
with chloroquine (see Fig.  1). 
DEPENDENCE  ON  PROTEIN SYNTHESIS"  ConfluentC6 
cells were  incubated  with  cycloheximide to  inhibit  protein 
synthesis. Measuring the incorporation of [~4C]leucine showed 
that incubating the cells for 2 h with 10 ug/ml cycloheximide 
at  37°C  inhibited  protein  synthesis  by  ~90%  (data  not 
shown).  Saturation-binding  experiments  with  [3H]CGP- 
12177  showed that cycloheximide did  not  alter KD signifi- 
cantly (0.43  _  0.4 nM, mean _  SD; n =  2) as determined by 
linear regression of Scatchard plot analysis @2 >_ 0.92).  Table 
II shows  that  preincubation  with  cycloheximide  inhibited 
inhibited the reappearance of the ¢~-adrenergic receptors (0). 
No inhibition was measured when 5 mM EGTA was added 
together  with  l0  uM  A  23187  (©),  thus  decreasing  Ca  2÷ 
activity to a  calculated value of 16 nM  (pH 7.3).  Thus the 
effect of A  23187  is  due  to  the  altered  intracellular  Ca  2÷ 
activity. 
Diminishing monovalent cation gradients did not inhibit 
the desensitization of 13-adrenergic receptors (16).  To deter- 
mine whether reappearance of ~-adrenergic receptors is de- 
pendent on monovalent cation gradients, we used monovalent 
cation ionophores, i.e. valinomycin (an ionophore specific for 
K÷),  FCCP (a proton-ionophore), and  monensin  (an  iono- 
phore exchanging K +, Na  ÷,  H÷).  None of these ionophores 
affected  [3H]CGP-12177  binding  to  13-adrenergic  receptors 
(data not shown). Cells were incubated with  1 uM  1-isopro- 
terenol together with 50 uM monensin for 20 min at 37°C to 
diminish monovalent cation gradients. After washing the cells, 
50 ~M monensin was added again and the reappearance of ¢~- 
adrenergic receptors was determined. Fig.  5 B (O) shows that 
monensin inhibited the reappearance of the ~-adrenergic re- 
ceptors completely. In order to reduce K ÷ and H + gradients, 
cells were incubated with isoproterenol plus 5 uM valinomy- 
cin and  50 uM FCCP for 20 rain at 37°C.  To prevent side 
effects by  uncoupling  of mitochondrial  electron  transport 
chain by FCCP, antimycin A was added, too. After the cells 
were  washed,  FCCP,  valinomycin,  and  antimycin  A  were 
added  again to the  suspension,  and the reappearance of/3- 
adrenergic receptors was determined. Fig.  5 B (©) shows that 
under these conditions, i.e., diminishing K*/H  + gradients, the 
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FIGURE  6  Inhibition  of reappearance  of binding  sites after chloro- 
quine treatment. Cells were pretreated with 100 #M chloroquine 
at 37°C for 4 h, and 1 #M isoproterenol was added (open symbols) 
or 0.017  mM ascorbic acid (closed symbols) for an additional 15 
min. After washing the cells,  100 #M chloroquine was added and 
the  binding assay was performed with  [3H]CGP-12177  at either 
37°C for 90 min (squares) or 4°C for 24 h (circles). 
HFRTEL AND  STAEHELIN  Transient  Decrease of ~-Adrenergic Receptors  1 541 TABLE  II 
Effect of Cycloheximide on Reversible Disappearance of t3- 
Adrenergic Receptors 
Bound, fmol/106 cells 
Addition  0°C  +37°C 
None  19.6 _  0.1  19,6 +  0.1 
Isoproterenol  15.7 +  0.2  19.8 +  0.6 
Isoproterenol +  cycloheximide  14.5 __ 0.1  19.2 +  0.1 
Cells were treated with or without  1 /~M isoproterenol for 20 rnin at 37"C. 
Preincubation  with 10 ug/ml cycloheximide was performed at 37"C for 2 h. 
The number of/~-adrenergic receptors was determined with 3 nM [~H]CGP- 
12177 incubating for 24 h at O°C with or without 90-rnin  preincubation at 
30°C (mean +  SD; n =  2). 
neither the disappearance of binding sites for CGP- 12177 nor 
the reappearance of these binding sites. 
DISCUSSION 
The desensitization of adenylate cyclase in cells containing/3- 
adrenergic  receptors  is  induced  by exposure  to  adrenergic 
agonists such as isoproterenol (1,  19). This desensitization of 
the adenylate cyclase is not accomplished by a loss in the total 
number of receptors (20).  It has been proposed that this is 
due to a change of the conformation of the receptor enzyme 
complex (21).  However, it has been shown that when astro- 
cytoma (5)  or C6-glioma cells were desensitized,  a  second 
vesicular receptor population occurred, which was not cou- 
pled to adenylate cyclase. Perkins (22)  has shown that the 
occurrence of this vesicular receptor population is transient. 
He and Harden et al. (5) proposed that the desensitization of 
the ~-adrenergic receptor is due to a reversible endocytosis of 
the  receptors.  This  has  been  supported  by  Staehelin  and 
Simons (9), who demonstrated a reversible disappearance of 
/~-adrenergic  receptors in C6-glioma and WEH17 lymphoma 
cells,  using the new hydrophilic antagonist [3H]CGP- 12177. 
In contrast to more lipophilic antagonists, such as dihydroal- 
prenolol (DHA), it has been demonstrated that CGP-12177 
possesses very little  nonspecific  binding  in  intact  cells  (7), 
which is due to the fact that CGP-12177 is not accumulated 
inside cells, while DHA is accumulated (8). A comparison of 
the binding of CGP- 12177 and DHA to intact cells pretreated 
with 1 #M isoproterenol for up to 20 min showed that DHA 
still  bound  to as many receptors as in  control cells,  while 
CGP-12177 bound to only 60-70% of the receptors present 
in control cells (9). It was therefore concluded that because of 
the  special  properties of CGP-12177,  i.e.,  membrane  im- 
permeability,  those  receptors  that  still  bind  DHA  but  no 
longer CGP-12177 are located inside the cells. In addition, in 
desensitized cells it has been possible to separate, by sucrose 
density gradient centrifugation, those receptors that bind only 
DHA, from plasma membrane receptors that bind DHA as 
well as CGP-12177 (34). The former are localized in vesicles 
and become accessible for [3H]CGP-12177 in the presence of 
the pore-forming agent alamethicin. 
We used [3H]CGP-12177 to investigate further the proper- 
ties of the  reappearance of/~-adrenergic receptors after the 
desensitization. 
De novo synthesis of the receptors was not involved in their 
reappearance, because treatment with cycloheximide (10 ug/ 
ml;  2  h),  which  inhibited  [~4C]leucine  incorporation  into 
proteins by 90%,  did  not  prevent the  reappearance of the 
receptors. 
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The  nonlinear  temperature  dependence  of the  receptor 
reappearance suggests  that this process is membrane medi- 
ated. An estimation of the Q,o gave two values of ~4.0 for T 
below 20°C  and  ~2.6  for those above 20°C  (by definition: 
Q~o =  Vr+~o/Vr; where Vis rate of reaction, Tis temperature 
in °C). Such a biphasic profile is characteristic of  a membrane- 
mediated process, because membranes have a melting point 
which is roughly at 20°C (23). 
Moreover, the reappearance of the receptors is dependent 
on an intact cell structure, because it was completely inhibited 
by lysing the cells (Fig. 2). Ion gradients will be dissipated by 
the  cell  lysis.  Therefore we  have  investigated  the  possible 
influence  of the  different  ion  gradients  on  reappearance. 
Increased intracellular Ca  2+ activity did inhibit the reappear- 
ance of the receptors, but had no effect on their disappearance 
(Fig.  5).  A  possible explanation  may be the disassembly of 
microtubules induced  by high  Ca  2+ activity (24).  Thus  the 
reappearance of the ¢/-adrenergic  receptors may require intact 
microtubules. 
The other cation gradients were altered by means of the 
following  ionophores:  monensin;  exchanging  Na  +,  K +,  H + 
against each other; valinomyein; transporting K ÷ and FCCP; 
transporting H ÷. Decreasing K÷/H  + gradients by valinomycin 
plus FCCP slightly inhibited reappearance of receptors, while 
diminishing H+/Na+/K  + gradients by monensin inhibited the 
latter completely (Fig.  5). Gradients of H+/Na÷/K  + occur at 
the plasma membrane (25) and intracellular membranes, e.g., 
membranes of endocytotic vesicles (26),  Golgi  membranes 
(27,  28),  and lysosomal membranes (17).  H+/Na  + gradients 
are considered  necessary for fusion  of endocytotic  vesicles 
with Golgi-derived particles and lysosomes (26). Moreover, it 
has been shown that monensin  inhibits recycling only, but 
not  internalization  of the  low density  lipoprotein-receptor 
(29). Our results show that monensin inhibited the reappear- 
ance but not the disappearance (16) of the/~-adrenergic recep- 
tors. Therefore, we suggest  that the transient disappearance 
of the ~-adrenergic receptors is caused by a mechanism anal- 
ogous to that described for the low density lipoprotein-recep- 
tor, namely an endocytosis cycle (29). 
Furthermore,  in  contrast to the disappearance, the  reap- 
pearance of the ~-adrenergic receptors was ATP dependent 
(Fig. 4). Preventing the ATP production by inhibiting glycol- 
ysis and the mitochondrial respiratory chain did impede the 
reappearance of the/3-adrenergic receptor. It has been sug- 
gested  that  the  intracellular  recycling  of receptors  is ATP 
dependent (30, 31). 
The fact that the lysosomotropic agent chloroquine, which 
is accumulated  by intact  cells  into  the  iysosomes (17),  in- 
hibited the reappearance of the #-adrenergic receptors (Fig. 
6), provides additional supporting evidence for an intracellu- 
lar cycling of the/3-adrenergic receptor. The inhibitory effect 
of chloroquine on the recycling of membrane antigens (32) 
and  mannose  glycoconjugate  receptors  (33)  has  been  de- 
scribed recently. This suggests  that intact lysosomes, with a 
normal low pH, may be a  prerequisite for reappearance of 
any receptors, including the ~-adrenergic receptor. 
The results obtained so far show that recycling of ~-adre- 
nergic receptors occurs and that this requires a low intracel- 
lular Ca  2+ activity, as well  as H+/Na  ÷ gradients,  ATP,  and 
intact  lysosomes.  However,  it  is  not  entirely  elucidated 
whether this process is taking place in the plasma membrane, 
or intracellularly.  Although  the  present  results support the 
latter  possibility,  we  cannot  exclude  the  occurrence  of a primary step in which  receptors become inaccessible within 
the plasma membrane, followed by endocytosis and intracel- 
lular recycling as a second step. 
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